Xiaoxi Zhang

779 total citations · 1 hit paper
19 papers, 572 citations indexed

About

Xiaoxi Zhang is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Xiaoxi Zhang has authored 19 papers receiving a total of 572 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Cardiology and Cardiovascular Medicine and 4 papers in Molecular Biology. Recurrent topics in Xiaoxi Zhang's work include Renin-Angiotensin System Studies (4 papers), Chronic Kidney Disease and Diabetes (3 papers) and Diabetes and associated disorders (3 papers). Xiaoxi Zhang is often cited by papers focused on Renin-Angiotensin System Studies (4 papers), Chronic Kidney Disease and Diabetes (3 papers) and Diabetes and associated disorders (3 papers). Xiaoxi Zhang collaborates with scholars based in China, United States and Italy. Xiaoxi Zhang's co-authors include Hai‐Lu Zhao, Yan-Hong Pan, Yong-chao Qiao, Yin-ling Chen, Fang Tian, Yan Xu, Lijun Geng, Jian Shen, Xuezhi Hong and Yongcheng Huang and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Xiaoxi Zhang

18 papers receiving 565 citations

Hit Papers

Encorafenib, cetuximab and chemotherapy in BRAF-mutant co... 2025 2026 2025 10 20 30
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: a randomized phase 3 trial
    2025 34 citations Scott Kopetz, Takayuki Yoshino et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoxi Zhang China 13 153 136 126 105 84 19 572
Beatriz Tavira Spain 18 74 0.5× 234 1.7× 105 0.8× 106 1.0× 61 0.7× 39 786
Yequn Chen China 15 95 0.6× 231 1.7× 63 0.5× 89 0.8× 126 1.5× 55 779
Hideki Horibe Japan 15 115 0.8× 293 2.2× 201 1.6× 69 0.7× 142 1.7× 65 716
Yin-ling Chen China 12 148 1.0× 95 0.7× 119 0.9× 108 1.0× 45 0.5× 22 511
Feng Bai China 14 144 0.9× 226 1.7× 56 0.4× 84 0.8× 93 1.1× 32 609
Ding Ding China 15 105 0.7× 193 1.4× 42 0.3× 130 1.2× 120 1.4× 27 716
Ndeye Coumba Ndiaye France 15 73 0.5× 175 1.3× 90 0.7× 78 0.7× 60 0.7× 35 555
Jayashree Shanker United Kingdom 17 89 0.6× 169 1.2× 137 1.1× 135 1.3× 109 1.3× 38 604
Yongjun Wang China 13 76 0.5× 168 1.2× 44 0.3× 77 0.7× 69 0.8× 45 539
Yi-Jen Hung Taiwan 14 130 0.8× 243 1.8× 52 0.4× 99 0.9× 71 0.8× 30 708

Countries citing papers authored by Xiaoxi Zhang

Since Specialization
Citations

This map shows the geographic impact of Xiaoxi Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoxi Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoxi Zhang more than expected).

Fields of papers citing papers by Xiaoxi Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoxi Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoxi Zhang. The network helps show where Xiaoxi Zhang may publish in the future.

Co-authorship network of co-authors of Xiaoxi Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoxi Zhang. A scholar is included among the top collaborators of Xiaoxi Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoxi Zhang. Xiaoxi Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Kopetz, Scott, Takayuki Yoshino, Eric Van Cutsem, et al.. (2025). Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: a randomized phase 3 trial. Nature Medicine. 31(3). 901–908. 34 indexed citations breakdown →
2.
Yoshino, Takayuki, Eric Van Cutsem, Cathy Eng, et al.. (2025). BREAKWATER: Analysis of first-line encorafenib + cetuximab + chemotherapy in BRAF V600E-mutant metastatic colorectal cancer.. Journal of Clinical Oncology. 43(4_suppl). 16–16. 2 indexed citations
3.
Huang, Wenjun, et al.. (2019). Endocrinological characterization of pancreatic ducts in HFD and HGD fed mice. Journal of Cellular Biochemistry. 120(9). 16153–16159. 14 indexed citations
4.
Qiao, Yong-chao, Min Wang, Yan-Hong Pan, et al.. (2018). The relationship between ACE/AGT gene polymorphisms and the risk of diabetic retinopathy in Chinese patients with type 2 diabetes. Journal of the Renin-Angiotensin-Aldosterone System. 19(1). 2688476795–2688476795. 10 indexed citations
5.
6.
Song, Jianfei, Xiaoxi Zhang, Xueping Hu, et al.. (2018). Association of Serum Angiopoietin-Like Protein 8 With Albuminuria in Type 2 Diabetic Patients: Results From the GDMD Study in China. Frontiers in Endocrinology. 9. 414–414. 13 indexed citations
7.
Qiao, Yong-chao, Yin-ling Chen, Yan-Hong Pan, et al.. (2017). The change of serum tumor necrosis factor alpha in patients with type 1 diabetes mellitus: A systematic review and meta-analysis. PLoS ONE. 12(4). e0176157–e0176157. 78 indexed citations
8.
Chen, Yin-ling, Yong-chao Qiao, Yan Xu, et al.. (2017). Serum TNF-α concentrations in type 2 diabetes mellitus patients and diabetic nephropathy patients: A systematic review and meta-analysis. Immunology Letters. 186. 52–58. 85 indexed citations
9.
Chen, Yin-ling, Yong-chao Qiao, Yan-Hong Pan, et al.. (2017). Correlation between serum interleukin-6 level and type 1 diabetes mellitus: A systematic review and meta-analysis. Cytokine. 94. 14–20. 56 indexed citations
10.
Qiao, Yong-chao, Jian Shen, Lan He, et al.. (2016). Changes of Regulatory T Cells and of Proinflammatory and Immunosuppressive Cytokines in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Journal of Diabetes Research. 2016. 1–19. 99 indexed citations
11.
Pan, Yan-Hong, Min Wang, Yanmei Huang, et al.. (2016). ACE Gene I/D Polymorphism and Obesity in 1,574 Patients with Type 2 Diabetes Mellitus. Disease Markers. 2016. 1–6. 22 indexed citations
12.
Wang, Min, Xiaoxi Zhang, Xia Zou, et al.. (2016). Nodular glomerulosclerosis and renin angiotensin system in Chinese patients with type 2 diabetes. Molecular and Cellular Endocrinology. 427. 92–100. 8 indexed citations
13.
14.
Zhang, Xiaoxi, Chen Wang, Li Li, et al.. (2016). Hepatitis C Virus Subtype and Evolution Characteristic Among Drug Users, Men Who Have Sex With Men, and the General Population in Beijing, China. Medicine. 95(6). e2688–e2688. 9 indexed citations
15.
Shen, Jian, Yanmei Huang, Min Wang, et al.. (2016). Renin–angiotensin system blockade for the risk of cancer and death. Journal of the Renin-Angiotensin-Aldosterone System. 17(3). 43 indexed citations
16.
Shen, Jian, Yanmei Huang, Xuezhi Hong, et al.. (2016). Protection against death and renal failure by renin-angiotensin system blockers in patients with diabetes and kidney disease. Journal of the Renin-Angiotensin-Aldosterone System. 17(3). 15 indexed citations
17.
Zou, Xia, Xiaoxi Zhang, Xinyu Liu, et al.. (2015). Renal Kallikrein Activation and Renoprotection after Dual Blockade of Renin-Angiotensin System in Diet-Induced Diabetic Nephropathy. Journal of Diabetes Research. 2015. 1–10. 11 indexed citations
18.
Jamieson, Catriona, Jörge E. Cortes, Vivian G. Oehler, et al.. (2011). Phase 1 Dose-Escalation Study of PF-04449913, An Oral Hedgehog (Hh) Inhibitor, in Patients with Select Hematologic Malignancies. Blood. 118(21). 424–424. 45 indexed citations
19.
Li, Shu‐Ming, Zhenhai Zhou, Shulin Jiang, et al.. (2011). [Incidence and risk factors of HIV and syphilis seroconversion among men who have sex with men in Beijing].. PubMed. 45(2). 118–22. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Beatriz Tavira Breakdown of academic impact, for papers by Yequn Chen Breakdown of academic impact, for papers by Hideki Horibe Breakdown of academic impact, for papers by Yin-ling Chen Breakdown of academic impact, for papers by Feng Bai Breakdown of academic impact, for papers by Ding Ding Breakdown of academic impact, for papers by Ndeye Coumba Ndiaye Breakdown of academic impact, for papers by Jayashree Shanker Breakdown of academic impact, for papers by Yongjun Wang Breakdown of academic impact, for papers by Yi-Jen Hung
Rankless by CCL
2026